Open AccessImmunological, Cognitive, and Psychiatric Outcomes After Initiating Efavirenz- and Dolutegravir-based Antiretroviral Therapy During Acute Human Immunodeficiency Virus Infection
Author(s) -
Phillip Chan,
Bohyung Yoon,
Donn Colby,
Eugène Kroon,
Carlo Sacdalan,
Somchai Sriplienchan,
Suteeraporn Pinyakorn,
Jintanat Ananworanich,
Victor Valcour,
Sandhya Vasan,
Denise C. Hsu,
Nittaya Phanuphak,
Robert Paul,
Serena Spudich
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac466
Subject(s) - medicine , dolutegravir , efavirenz , antiretroviral therapy , human immunodeficiency virus (hiv) , virology , psychiatry , immunology , pediatrics , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom